Agreement on Profit Based Settlement and Enoxaparin TransferAgreement on Profit Based Settlement and Enoxaparin Transfer • August 10th, 2020 • Momenta Pharmaceuticals Inc • Biological products, (no disgnostic substances) • New York
This Agreement on Profit Based Settlement and Enoxaparin Transfer (the “Agreement”) is effective as of July 10, 2020 (the “Effective Date”) between Sandoz AG, a company organized under the laws of Switzerland, Sandoz Inc., a Colorado corporation (Sandoz AG and Sandoz Inc., collectively the “Sandoz Parties,” each individually a “Sandoz Party”) and Momenta Pharmaceuticals, Inc., a Delaware corporation (“Momenta,” collectively with the Sandoz Parties, the “Parties,” each individually a “Party.”).
